SCHEMBL1443722

SCHEMBL1443722

CCCCCCCOS(C)(=O)=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.75
KDM4E B2RXH2 1/20 0.75
USP2 O75604 1/20 0.75
ALDH1A1 P00352 1/20 0.75
LMNA P02545 1/20 0.75
MMP9 P14780 1/20 0.75
ALOX15 P16050 1/20 0.75
CA1 P00915 15/20 0.64
CA2 P00918 15/20 0.64
CA9 Q16790 13/20 0.64
CA12 O43570 4/20 0.64
CA7 P43166 4/20 0.64
CA14 Q9ULX7 4/20 0.64
CA3 P07451 3/20 0.64
CA4 P22748 3/20 0.64
CA6 P23280 3/20 0.64
CA5A P35218 3/20 0.64
CA5B Q9Y2D0 3/20 0.64
RECQL P46063 2/20 0.61
GLA P06280 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11748392 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL5605250 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
Methanesulfonic Acid Dodecyl Ester SCHEMBL2223590 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL7726676 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL1899016 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL11225069 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL908020 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL3092383 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL140845 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL11236129 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376256-A1 ORGANIC BINDER, COMPOSITION FOR PRODUCING INORGANIC MATERIAL MOLDED ARTICLE, GREEN BODY, DEGREASED BODY, INORGANIC MATERIAL MOLDED ARTICLE, AND METHOD OF PRODUCING INORGANIC MATERIAL MOLDED ARTICLE KUREHA CORPORATION (JP) 2024-11-14 US disclosed
CN-117858872-A Heterocyclic EGFR inhibitors for the treatment of cancer 缆图药品公司 2024-04-09 CN disclosed
CN-111225896-B Immunomodulatory compounds 凯莫森特里克斯股份有限公司 2024-03-26 CN disclosed
CN-117529377-A Organic binder, composition for producing inorganic material molded body, green body, degreased body, inorganic material molded body, and method for producing inorganic material molded body 株式会社吴羽 2024-02-06 CN disclosed
CN-112574175-B Quinoline compound, preparation method and application thereof 南京长澳医药科技有限公司 2023-11-14 CN disclosed
CN-116940581-A Novel protein degradation agent and application thereof 和径医药科技(上海)有限公司 2023-10-24 CN disclosed
US-20230174561-A1 IONIC COMPOUND AND COMPOSITION THEREOF FOR HYDROPHOBIC PROTEIN EXTRACTION; AND ANTI-NONSPECIFIC PROTEIN ADSORPTION ZWITTERIONIC COMPOUND AND ELEMENT WITH ANTI-NONSPECIFIC PROTEIN ADSORPTION LAYER COMPRISING THE SAME YANQIN HOLDING COMPANY (TW) 2023-06-08 US disclosed
CN-111344891-B Nonaqueous electrolyte and energy device using same 三菱化学株式会社 2023-05-02 CN disclosed
WO-2023286509-A1 ORGANIC BINDER, COMPOSITION FOR PRODUCING INORGANIC MATERIAL MOLDED ARTICLE, GREEN BODY, DELIPIDATION BODY, INORGANIC MATERIAL MOLDED ARTICLE, AND INORGANIC MATERIAL MOLDED ARTICLE PRODUCTION METHOD 株式会社クレハ 2023-01-19 WO disclosed
CN-115315259-A Compounds useful for inhibition of ketohexokinase and methods of making and using the same 因奥必治疗有限公司 2022-11-08 CN disclosed
EP-0161904-B1 TETRAHYDROFURANYL AND TETRAHYDROTHIENYL SUBSTITUTED ETHERS E.R. Squibb & Sons, Inc. (US) 1989-10-18 EP disclosed
EP-0232912-A1 Hydroxamic acids of 7-oxabicycloheptane substituted ethers E.R. Squibb & Sons, Inc. (US) 1987-08-19 EP disclosed
US-4654366-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, ANTIPSORIATIC E. R. SQUIBB & SONS, INC. (US) 1987-03-31 US disclosed
US-4647585-A Bicycloheptane substituted ethers E. R. SQUIBB & SONS, INC. (US) 1987-03-03 US disclosed
US-4608386-A ASTHMA E. R. SQUIBB & SONS, INC. (US) 1986-08-26 US disclosed
EP-0163562-A1 7-Oxabicycloheptane substituted ethers E.R. Squibb & Sons, Inc. (US) 1985-12-04 EP disclosed
EP-0161904-A2 Tetrahydrofuranyl and tetrahydrothienyl substituted ethers E.R. Squibb & Sons, Inc. (US) 1985-11-21 EP disclosed
US-4550120-A BRONCHODILATOR AGENTS, ANALGESICS E. R. SQUIBB & SONS, INC. (US) 1985-10-29 US disclosed
US-4542151-A CARDIOVASCULAR, BRONCHODILATION, ANALGESICS, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1985-09-17 US disclosed
US-4521539-A ANALGESICS, CARDIONVASCULAR AND ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1985-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174561-A1 IONIC COMPOUND AND COMPOSITION THEREOF FOR HYDROPHOBIC PROTEIN EXTRACTION; AND ANTI-NONSPECIFIC PROTEIN ADSORPTION ZWITTERIONIC COMPOUND AND ELEMENT WITH ANTI-NONSPECIFIC PROTEIN ADSORPTION LAYER COMPRISING THE SAME FABP1, EBPL, FABP7 TSHR 3799/4885KDM4E 2814/4885USP2 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.